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Objective:  To determine the antimicrobial activity of rosemary (Rosmarinus officinalis L.) and to 
investigate the synergistic effects of this extract combined with ceforuxime against methicillin-
resistant Staphylococcus aureus (MRSA). Methods: The inhibitory and bactericidal activities of 
rosemary ethanol extract, alone and in combination with cefuroxime, were studied. Results: The 
minimum inhibitory concentrations (MICs) of the ethanol extract of rosemary were in the range 
of 0.39-3.13 mg/mL. The minimum bactericidal concentrations (MBCs) were usually equal to or 
double that MICs.  The antimicrobial activity of combinations of the ethanol extract of rosemary 
and cefuroxime indicated their synergistic effects against all MRSAs. Conclusions: The present 
work clearly demonstrates that rosemary has a key role in the elevation of susceptibility to 
毬-lactams.
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1. Introduction
  Methicillin-resistant Staphylococcus aureus (MRSA) has 
become a major nosocomial pathogen in the past 2 decades. 
Therapeutic options for MRSA infection are very limited 
because most MRSA strains are resistant not only to毬
-lactams but also to multiple antimicrobial agents, such 
as macrolides, aminoglycosides, and fluoroquinolones [1-4]. 
Numerous researches have been carried out to study the 
potential antimicrobial activity of rosemary extracts [5-8] but 
attention has not been focused deeply on studying the herb-
drug interaction between rosemary extracts and 毬-lactams 
against MRSA strains.
  The purpose of the present work was to determine the 
antimicrobial activity of rosemary ethanol extract and to 
investigate the synergistic effects of this extract combined 
with ceforuxime against MRSA, thereby throwing light on 
the potential role of rosemary in increasing the effectiveness 
of antibiotics. 
2. Materials and methods
2.1. Plant material and preparation of extract
  Rosmarinus officinalis was harvested in the northern area 
of Palestine in June 2009. Air-dried and powdered leaves 
were extracted with 80% ethanol. After filtration of total 
extracts, the extracts were evaporated to dryness at 40 ℃ 
and weighed. 
2.2. Bacterial strains
  Five clinical MRSA isolates were used in the study. A 
standard bacteria strain of Staphylococcus aureus ATCC 
25923 was also used as control.
2.3. Antibacterial activity
  Antibacterial activity was determined by the well diffusion 
method according to the NCCLS [9]. Petri plates containing 
Mueller Hinton agar medium were seeded with a 24 h 
culture of the bacterial strains. Wells (6 mm diameter) were 
cut into the agar and 50 滋L of the plant extracts were tested 
in a concentration of 100 mg/mL. The inoculum size was 
adjusted so as to deliver a final inoculum of approximately 
108 colony-forming units (CFU)/mL. Incubation was 
performed at 37 ℃ for 24 h. The assessment of antibacterial 
activity was based on measurement of the diameter of the 
inhibition zone formed around the well. A standard 30 滋g 
cefuroxime disk was used as a positive control. 
  Minimum inhibitory concentrations (MICs) were determined 
by the microbroth dilution method described by the National 
Committee for Clinical Laboratory Standards [10]. The range 
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of ceforuxime and plant extracts dilutions were 0.016 mg/
mL to 0.000 125 mg/mL and 50 mg/mL to 0.195 mg/mL in 
Mueller-Hinton broth (Difco Laboratories), respectively. A 
final concentration of 1×105 CFU/mL of test bacteria was 
added to each dilution. The tubes were incubated at 37 ℃ 
for 48 h. MIC was defined as the lowest concentration of 
antimicrobial agent that inhibited bacterial growth, as 
indicated by the absence of turbidity. Each test included two 
growth controls consisting of the medium with the solvent 
and medium with bacterial suspension as well as sterility 
control. All tests were performed in duplicates.
  Minimum bactericidal concentrations (MBCs) were 
determined by inoculating a 10 滋L of medium from each of 
the wells from the MIC test which showed no turbidity onto 
a fresh drug-free agar plates. MBCs were defined as the 
lowest concentration of antimicrobial agent where was no 
bacterial growth on the plates.
2.4. Evaluation of synergy between plant extracts and 
antibiotics
  This evaluation was done according to Muroi and Kubo [11]. 
Aliquots of 100 滋L of bacterial cultures (105 CFU/ mL) were 
inoculated in Mueller-Hinton broth supplemented with 
ceforuxime at a concentration corresponding to 1/2 MIC with 
different concentrations of plant extracts. The concentration 
for plant extracts ranged from 1/32×MIC to 2×MIC, based 
on MIC values, that had previously been evaluated. 
2.5. FIC testing
  The fractional inhibitory concentration (FIC) was derived 
from the lowest concentration of antibiotic and extract 
combination permitting no visible growth of the test 
organisms on the plates [12]. The FIC value for each agent 
was calculated using the formula: 
  FIC(antibiotic) 
 = MIC of antibiotic in combination / MIC of antibiotic alone 
                                                                                          
  FIC (extract) 
 = MIC of extract in combination / MIC of extract alone             
  Combinations were classified as synergistic, if the FIC 
indices were <1, additive if the FIC indices were = 1, 
indifferent if the FIC indices were between 1 and 2 and 
antagonistic if the FIC indices were >2 [13]. 
3. Results
  Antimicrobial screening tests of the ethanol extract of 
rosemary was assayed in vitro by agar well diffusion method 
against 5 clinical MRSA isolates and Staphylococcus aureus 
ATCC 25923 (Table 1). Zones of inhibition ranged from 
16 to >28 mm against all the test isolates. The significant 
antibacterial activity of the active plant extracts was 
comparable to the standard antimicrobics, ceforuxime (30 滋
g/disc).
  The MICs of the extracts and the antibiotics varied between 
0.000 125 mg/mL and 3.13 mg/mL (Table 1).  Specifically, 
the MICs ranged from 0.39-3.13 mg/mL for rosemary on all 
of isolates tested. For the standard antibiotics, the ranges 
were 0.000 125-0.008 mg/mL for cefuroxime. The MBC of 
both rosemary extract and cefuroxime was usually equal to 
or double that MIC, except in the case of cefuroxime against 
MRSA-5 where the MBC was four times more than the MIC 
(Table 1). 
Table 1
Antibacterial activity of cefuroxime and Rosmarinus officinalis 
extracts.
Test isolate
Cefuroxime
(positive control)
Rosmarinus officinalis 
ethanol extract
30 滋g 
per disk
MIC
(mg/mL)
5 mg 
per well
MIC
(mg/mL)
MRSA-1*
6 0.008 20 0.78
MRSA-2 
11 0.001 16 1.56
MRSA-3 
10 0.002 16 1.56
MRSA-4 
10 0.002 17 3.13
MRSA-5
14 0.001 23 0.78
Staphylococcus aureus 
ATCC 25923
>26 0.000 125 >28 0.39
* Methicillin-resistant Staphylococcus aureus. Diameter of the zone of 
inhibition (mm) including the diameter of well (6 mm). 
Table 2 
Fractional inhibitory concentration (FIC) values for the combinations 
between cefuroxime and Rosmarinus officinalis extracts.
Test isolate
FIC
(Cefuroxime)
FIC
(Extract)
FIC
Index
Interaction
MRSA-1 0.500 0.063 0.563 Synergy
MRSA-2 0.500 0.063 0.563 Synergy
MRSA-3 0.500 0.125 0.625 Synergy
MRSA-4 0.500 0.246 0.746 Synergy
MRSA-5 0.500 0.501 1.000 Synergy
  The interpretations of the activity of rosemary extract 
combined with cefuroxime produced a remarkable 
synergistic activity against the tested 5 MRSA isolates 
(Table 2). The MICs of rosemary extracts for the MRSAs 
were decreased from the range of (0.78-0.049) to (0.49-
0.39) mg/mL when these extracts were combined with 
cefuroxime at a concentration corresponding to 1/2 MIC.
4. Discussion
  MRSA is resistant to virtually all kinds of 毬-lactams, and 
it thereby threatens the most potent antibiotics we have [1-4]. 
To recover the毬-lactams efficiency, we investigated the 
antibacterial activity of rosemary extract, and cefuroxime 
alone and in combination on the susceptibility of MRSAs. 
  The results of disc diffusion support and extend previous 
findings  that rosemary contains numerous biologically 
active compounds and some of these have been frequently 
used in folk medicine for their antimicrobial properties. 
  In addition, the MIC and MBC values support the findings 
of the diffusion method. The biological activity of rosemary 
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against the tested bacteria could be attributed to the 
presence of flavonoids, phenolic acids (caffeic, chorogenic 
and rosmarinic) and essencial oils (camphor and cineole) 
and diterpenes (carnosol) [14-16].
  The area of concern is that MIC values of the active plant 
extracts obtained in this study were lower than the MBC 
values, suggesting that the plant extracts were bacteriostatic 
at lower concentration and bactericidal at higher 
concentration.
  In the present study, rosemary exhibits remarkable 
synergistic activity in combination with cefuroxime, which 
is reflected by changes in the MIC values of the test MRSAs 
(FIC index range for synergism, 0.56 to 1.00). Although the 
level of antibiotic potentiation was low, the results seem 
promising considering that crude extracts were used. The 
potentiation is likely to have been much more pronounced if 
pure compounds were used.
  Although the synergistic effects resulting from the 
combination of antibiotics with extracts were documented 
in the literature [17-19], the mechanism governing the joint 
action of rosemary extract components and antibiotics 
is still unknown. This may be due to the large number 
of different groups of chemical compounds present in 
rosemary extracts [14-16]. Biologically active components are 
believed to disturb permeability of the cytoplasm membrane 
and thereby facilitate the influx of antibiotics [20].
  The results presented in this report highlight the potential 
of rosemary extract as a source of antibiotic resistance 
modifying compounds.  Further work is presently under way 
to characterize the action mechanisms of these interesting 
compounds responsible for the synergistic activity against 
MRSAs.
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